A Alo1, S Gounder1, S M Graham2. 1. National Tuberculosis Program, Ministry of Health, Suva, Fiji. 2. Centre for International Child Health, University of Melbourne and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia ; International Union Against Tuberculosis and Lung Disease, Paris, France.
Abstract
SETTINGS: Tuberculosis (TB) is an ongoing public health challenge in Fiji. Clinical case detection and management are critical for effective TB control. Most TB cases in Fiji are hospitalised for the intensive phase of treatment. OBJECTIVES: To describe the demographic and clinical characteristics, comorbidities and final treatment outcomes of TB patients hospitalised for the intensive phase of treatment in Fiji. DESIGN: A retrospective, descriptive study of all TB cases hospitalised during the intensive phase over a 3-year period (2010-2012). RESULTS: A total of 395 TB hospitalised cases were included, of whom 61% were sputum smear-positive. The largest proportions of cases were among young adults (15-34 years) and the unemployed, respectively 43% and 71%. Diabetes (13%) and smoking (22%) were common comorbidities. Final anti-tuberculosis treatment outcomes were available for 96% of cases; 81% were cured or completed treatment. Default was more common in those with current employment. Death was the final treatment outcome in 4%, and was more common (11%) in the oldest group aged 355 years (OR 5.7, 95%CI 1.9-17). CONCLUSION: This study provides original and comprehensive descriptive data on TB cases in Fiji and identifies characteristics associated with poor treatment outcomes.
SETTINGS: Tuberculosis (TB) is an ongoing public health challenge in Fiji. Clinical case detection and management are critical for effective TB control. Most TB cases in Fiji are hospitalised for the intensive phase of treatment. OBJECTIVES: To describe the demographic and clinical characteristics, comorbidities and final treatment outcomes of TB patients hospitalised for the intensive phase of treatment in Fiji. DESIGN: A retrospective, descriptive study of all TB cases hospitalised during the intensive phase over a 3-year period (2010-2012). RESULTS: A total of 395 TB hospitalised cases were included, of whom 61% were sputum smear-positive. The largest proportions of cases were among young adults (15-34 years) and the unemployed, respectively 43% and 71%. Diabetes (13%) and smoking (22%) were common comorbidities. Final anti-tuberculosis treatment outcomes were available for 96% of cases; 81% were cured or completed treatment. Default was more common in those with current employment. Death was the final treatment outcome in 4%, and was more common (11%) in the oldest group aged 355 years (OR 5.7, 95%CI 1.9-17). CONCLUSION: This study provides original and comprehensive descriptive data on TB cases in Fiji and identifies characteristics associated with poor treatment outcomes.
Authors: Giovanni Ferrara; Megan Murray; Kevin Winthrop; Rosella Centis; Giovanni Sotgiu; Giovanni Battista Migliori; Markus Maeurer; Alimuddin Zumla Journal: Curr Opin Pulm Med Date: 2012-05 Impact factor: 3.155
Authors: Anthony D Harries; Rony Zachariah; Elizabeth L Corbett; Stephen D Lawn; Ezio T Santos-Filho; Rhehab Chimzizi; Mark Harrington; Dermot Maher; Brian G Williams; Kevin M De Cock Journal: Lancet Date: 2010-05-18 Impact factor: 79.321
Authors: Sun Ha Jee; Jonathan E Golub; Jaeseong Jo; Il Su Park; Heechoul Ohrr; Jonathan M Samet Journal: Am J Epidemiol Date: 2009-11-16 Impact factor: 4.897
Authors: Meghan A Baker; Anthony D Harries; Christie Y Jeon; Jessica E Hart; Anil Kapur; Knut Lönnroth; Salah-Eddine Ottmani; Sunali D Goonesekera; Megan B Murray Journal: BMC Med Date: 2011-07-01 Impact factor: 8.775